Dendritic Cell/Tumor Fusion Vaccine

BIOLOGICAL3 trials

Sponsors

Beth Israel Deaconess Medical Center, Second Affiliated Hospital, School of Medicine, Zhejiang University

Conditions

Breast CancerFallopian Tube CancerGlioblastomaGliomaImmunologic FactorsNeoplasmsNeoplasms, Nerve TissueNeoplasms, Neuroepithelial

Phase 1

Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12

TerminatedNCT00622401

Beth Israel Deaconess Medical CenterBreast Cancer

Start: 2009-12-31End: 2014-10-31Updated: 2017-11-14

Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients.

Second Affiliated Hospital, School of Medicine, Zhejiang UniversityGlioblastoma, Glioma, Immunologic Factors +5

Start: 2020-12-31End: 2023-12-31Target: 10Updated: 2020-06-09

Phase 2

Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod

Active, not recruitingNCT00799110

Beth Israel Deaconess Medical CenterFallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cancer

Start: 2008-08-31End: 2024-12-31Target: 23Updated: 2024-06-11